Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes.

Liu, Bing-Li; Yin, Guo-Ping; Li, Feng-Fei; Hu, Yun; Wu, Jin-Dan; Chen, Mao-Yuan; Ye, Lei; Su, Xiao-Fei; Ma, Jian-Hua

Liu, Bing-Li; Yin, Guo-Ping; Li, Feng-Fei; Hu, Yun; Wu, Jin-Dan; Chen, Mao-Yuan; Ye, Lei; Su, Xiao-Fei; Ma, Jian-Hua.

Afiliação

Liu BL; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yin GP; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Li FF; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Hu Y; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Wu JD; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Chen MY; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Ye L; National Heart Centre Singapore, National Heart Research Institute Singapore, Singapore.
Su XF; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Ma JH; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Int J Endocrinol ; 2018: 2087960, 2018.

Article em En | MEDLINE | ID: mdl-29780415

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article